WVE
Wave Life SciencesCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
WVE vs peer average
52/100
WVE vs. peer average (C vs. C)
Grade spread
A 2 · C 4 · D 3 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
BEAM is the first available peer comparator.
Beam is the closest platform-style peer because it is also a high-risk gene/RNA-editing company where clinical proof and regulatory credibility drive valuation. Wave could receive renewed platform optionality if WVE-006 develops a clearer registrational path, but both names remain milestone- and data-dependent.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
WVE
Wave Life Sciences
BEAM
Beam Therapeutics
Grade
C
A
Momentum
4
19
Value
41
41
Sentiment
77
95
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs BEAM
WVE / BEAM
Grade Position
In line
WVE vs. peer average (C vs. C)
52/100
Momentum
4
BEAMValue
41
WVESentiment
77
BEAMRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs WVE
BEAM is the first peer returned for this comparison set.

